Funded Tech Companies

Eidos Therapeutics

Wondering who backed Eidos Therapeutics? BridgeBio Pharma, Aisling Capital and RA Capital invested in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. Eidos seeks to treat this well-defined family of diseases at their collective source by stabilizing TTR.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/6/2018

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Neil Kumar

        

Chief Financial Officer

Christine Siu

        

Chief Medical Officer

Jonathan Fox

        

Chief Scientific Officer

Uma Sinha

        

VP - Bus. Development

Cameron Turtle

        

Company Investors

• BridgeBio Pharma
• Aisling Capital (Eric Aguiar)
• RA Capital (Rajeev Shah)
• Amzak Health Investors
• Viking Global Investors
• Cormorant Asset Management
• Perceptive Advisors
• Janus Capital

Browse more funded tech companies:

eHealth Technologies | Eigen Innovations

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary